Article info

Download PDFPDF

Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study
Free

Authors

  1. Correspondence to Professor Carlo Salvarani, Unit of Rheumatology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Emilia-Romagna, Italy; carlo.salvarani{at}ausl.re.it
View Full Text

Citation

Salvarani C, Bajocchi G, Mancuso P, et al
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study

Publication history

  • Received May 7, 2020
  • Revised May 16, 2020
  • Accepted May 17, 2020
  • First published May 28, 2020.
Online issue publication 
June 14, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.